483
Tianjin Institute of Pharmaceutical Research New Drug Evaluation Co. LtdTianjin Institute of Pharmaceutical Research New Drug Evaluation Co. Ltd – FDA 483, May 19, 2025
Record Details
An FDA inspection of Tianjin Institute of Pharmaceutical Res. New Drug Eval. Co., Ltd, a nonclinical laboratory, revealed significant deficiencies across multiple areas. Observations included inadequate cleaning and sanitation of animal housing, poor facility maintenance, and failures in retaining reserve samples. Additionally, issues were noted with equipment maintenance records, accurate data recording, and adherence to standard operating procedures and study protocols.
- Inspection date
- May 19, 2025
- Product type
- drugs
View Company Profile
ID · 9d4734df-d95f-447f-a2ae-4c55e3e2caca
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.